After a successful legislative operation to remove roadblocks to new drugs and devices, lawmakers behind the 21st Century Cures law will continue to conduct regular checkups.
“We’re going to make sure the money is well spent,” Rep. Fred Upton (R-Mich.) told Bloomberg Law, adding that programmatic oversight of the law will continue as well. “Where we need to come in to fix it, you’ll see us do it.”
Cures, which often is considered Upton’s legacy project, became law shortly before his chairmanship on the House Energy and Commerce Committee expired at the end of 2016. Upton and his Cures co-pilot ...